Physician profile
Samuel Clellen
NPI 1124607585
$29,077.06
in general payments reported to CMS, 2019-2025
21 companies · $25K in 2025
The $25K reported for 2025 was more than what 99% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $4,382 · 2025: $25K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Grant: $10K · Travel and Lodging: $9,074.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,002.58 |
| Grant | $10,000.00 |
| Travel and Lodging | $9,074.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $10,462.45 | 2025 | |
| Stryker Corporation | $9,381.17 | 2024-2025 | Ortholoc 3di, Augment Injectable, Ortholoc 2 Lapifuse |
| Paragon 28, INC. | $2,612.45 | 2024-2025 | Portfolio, R3flex |
| Treace Medical Concepts, INC. | $2,159.29 | 2024-2025 | |
| Novus Surgical Consultants | $1,197.97 | 2024-2025 | |
| Integra Lifesciences Corporation | $721.64 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kerecis Limited | $560.52 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Medline Industries LP | $368.45 | 2025 | |
| Amgen INC. | $233.68 | 2024 | Krystexxa |
| Blue Surgical LLC | $228.17 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $153.75 | 2025 | |
| Southern Edge Orthopaedics, INC. | $133.36 | 2024 | |
| Lifenet Health | $131.25 | 2025 | Theragenesis Wound Matrix |
| Bone Support INC. | $127.63 | 2025 | Ceramentbone Void Filler, Cerament G |
| Linvatec Corporation | $116.39 | 2024 | 5ms, Colink 2 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $107.45 | 2024-2025 | Prevena Restor Axioform, V.A.C. Veraflo Cleanse Choice, Activ.A.C. |
| Avita Medical Americas, LLC | $101.49 | 2025 | Recell, Permeaderm, Cohealyx |
| Convatec INC. | $87.95 | 2025 | |
| Medtronic, INC. | $85.43 | 2025 | Inceptiv |
| Trice Medical, INC. | $71.43 | 2024 | |
| Smith+Nephew, INC. | $35.14 | 2024-2025 | Renasys Touch, Grafix Pl, Stravix Pl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Clellen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.